Brussels, March 20, 2024, 08:30 CET - Regulated information
In line with Belgian transparency legislation (Law of May 2, 2007), DME Advisors
and DME Capital Management recently sent to Solvay the following transparency
notification indicating that they crossed the threshold of 5%.
The notification, dated March 15, 2024, contains the following information:
* Reason for the notification: acquisition or disposal of voting securities or

    voting rights Notified by: A parent undertaking or a controlling person
  * Date on which the threshold is crossed: March 8, 2024
  * Threshold of direct voting rights crossed: 5% upwards
  * Denominator: 105,876,416
  * Full chain of controlled undertakings through which the holding is
    effectively held: DME Advisors, LP and DME Capital Management, LP are
    controlled by DME Advisors GP, LLC. DME Advisors GP, LLC is controlled by
    David Einhorn.
  * Additional information: DME Advisors, LP and DME Management LP are the
    discretionary investment managers and exercise the voting rights at their
    discretion in the absence of specific instructions.
  * Persons subject to the notification requirement:
 Name                       Address (for legal entities)
 David Einhorn              140 East 45th Street, 24th Floor, New York, NY
                            10023, USA
 DME Advisors GP, LLC       Corporation Trust Center, 1209 Orange Street,
                            Wilmington, DE 19801, USA

DME Capital Management, LP Corporation Trust Center, 1209 Orange Street,

                            Wilmington, DE 19801, USA
 DME Advisors, LP           Corporation Trust Center, 1209 Orange Street,
                            Wilmington, DE 19801, USA

Â